Literature DB >> 35949017

Endonasal Endoscopic Removal of Orbital Cavernous Venous Malformation With Optic Neuropathy.

Jung Yul Park1,2, Kyu-Sup Cho3,2, Yu Bin Son1, Hee-Young Choi1,2.   

Abstract

Several surgical methods have been employed, but the management of orbital cavernous venous malformations at the orbital apex remains challenging. The authors present an endonasal endoscopy-assisted removal of an orbital apex cavernous venous malformation compressing the optic nerve with the addition of an inferomedial conjunctival approach. A 43-year-old Asian man presented with an orbital cavernous venous malformation incidentally found radiographically with a history of decreased vision of 20/50 oculus dexter (OD). The patient's visual field index was 22%, with signs of optic neuropathy. An endonasal endoscopic procedure combining transconjunctival and caruncular orbitotomies was adopted because of its deep posterior placement inside the orbit. The cavernous venous malformation was removed without complications, and the visual function of the patients recovered. For these challenging lesions, an endonasal endoscopic technique with an anterior orbitotomy may be a promising alternative. Simple packing material may adequately repair the medial orbital wall; there were no complications during the 12-month follow-up period.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Mutaz B. Habal, MD.

Entities:  

Mesh:

Year:  2022        PMID: 35949017      PMCID: PMC9432810          DOI: 10.1097/SCS.0000000000008720

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.172


  9 in total

1.  Transnasal endoscopic removal of an orbital cavernoma.

Authors:  P Herman; G Lot; B Silhouette; R Marianowski; F Portier; M Wassef; P T Huy
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-02       Impact factor: 1.547

Review 2.  Purely endoscopic trans-nasal management of orbital intraconal cavernous haemangiomas: a systematic review of the literature.

Authors:  Riccardo Lenzi; Benjamin S Bleier; Giovanni Felisati; Luca Muscatello
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-26       Impact factor: 2.503

3.  Cavernous hemangioma of the orbital apex: pathogenetic considerations in surgical management.

Authors:  Gerald J Harris
Journal:  Am J Ophthalmol       Date:  2010-12       Impact factor: 5.258

4.  Surgical outcomes of transconjunctival anterior orbitotomy for intraconal orbital cavernous hemangioma.

Authors:  Kyong Jin Cho; Ji-Sun Paik; Suk-Woo Yang
Journal:  Korean J Ophthalmol       Date:  2010-10-05

5.  Orbital apex venous cavernous malformation with optic neuropathy: treatment with multisession gamma knife radiosurgery.

Authors:  Stephanie Ming Young; Kyung Hwan Kim; Yoon-Duck Kim; Stephanie S Lang; Ji Woong Park; Kyung In Woo; Jung-Il Lee
Journal:  Br J Ophthalmol       Date:  2019-01-05       Impact factor: 4.638

6.  Combined Endonasal and Orbital Approach for Resection of Orbital Apical Tumors.

Authors:  Liza M Cohen; Seanna R Grob; Kenneth B Krantz; Kenneth A Feldman; Daniel B Rootman
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2022-02-15       Impact factor: 2.011

7.  Endoscopic transethmoidal approach with or without medial rectus detachment for orbital apical cavernous hemangiomas.

Authors:  Wencan Wu; Dinesh Selva; Fangzheng Jiang; Wentao Jing; Yunhai Tu; Ben Chen; Jieliang Shi; Michelle T Sun; Jia Qu
Journal:  Am J Ophthalmol       Date:  2013-06-28       Impact factor: 5.258

8.  Cavernous venous malformations of the orbit (so-called cavernous haemangioma): a comprehensive evaluation of their clinical, imaging and histologic nature.

Authors:  Dan B Rootman; Manraj K S Heran; Jack Rootman; Valerie A White; Panitee Luemsamran; Yeni H Yucel
Journal:  Br J Ophthalmol       Date:  2014-07       Impact factor: 4.638

9.  Transnasal Endoscopic Sclerotherapy for Orbital Apex Lymphatic Malformation.

Authors:  Stephanie S L Cheung; Stacey C Lam; Hunter K L Yuen
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 May-Jun 01       Impact factor: 1.746

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.